Association of Toll-like receptor polymorphism and gene expression level with the risk of developing chronic obstructive pulmonary disease (COPD) and its severity

被引:0
作者
Salamaikina, S. A. [1 ,2 ]
Korchagin, V. I. [1 ]
Mironov, K. O. [1 ]
Karnaushkina, M. A. [3 ]
机构
[1] Russian Fed Serv Surveillance Consumer Rights Prot, Cent Res Inst Epidemiol, 3a Novogireevskaya Str, Moscow 111123, Russia
[2] Moscow Inst Phys & Technol MIPT, 9 Inst Sky Lane, Dolgoprudnyi 141701, Russia
[3] Patrice Lumumba Peoples Friendship Univ Russia, RUDN Univ, 6 Miklukho Maklaya Str, Moscow 117198, Russia
来源
BYULLETEN SIBIRSKOY MEDITSINY | 2025年 / 24卷 / 01期
关键词
COPD; TLR; single nucleotide polymorphisms; gene expression;
D O I
10.20538/1682-0363-2025-1-77-85
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. Determine the influence of genetic factors of innate immunity on the risk of development and severity of COPD. Materials and methods. The study included 103 patients diagnosed with chronic obstructive pulmonary disease and 47 conditionally healthy people without any chronic bronchopulmonary pathologies. The expression level of TLR genes and alleles of rs5743551 (TLR1), rs5743708 (TLR2), rs3804100 (TLR2), rs3806790 (TLR4), rs5743810 (TLR6), rs3804880 (TLR8) single nucleotide polymorphisms were analyzed via real-time polymerase chain reaction (PCR). Results. Several tendencies were observed: an increase in the proportion of GG homozygotes in the rs5743810 (TLR6) locus in patients with severe COPD and a negative correlation between TLR2 and TLR6 genes expression level and oxygen saturation in blood, dyspnea and COPD severity. Conclusion. No statistically significant association with rs5743551 (TLR1), rs5743708 (TLR2), rs3804100 (TLR2), rs4986790 (TLR4), rs5743810 (TLR6), rs3764880 (TLR8) single nucleotide polymorphisms was found. The observed tendency of the TLR gene expression level increase may be associated with the remodeling of lung tissues and activation of the immune response that occur during COPD.
引用
收藏
页数:196
相关论文
共 25 条
[1]  
Amirova T.O, 2022, Pul'monologiya, V32, P608, DOI [10.18093/0869-0189-2022-32-4-608-615, DOI 10.18093/0869-0189-2022-32-4-608-615]
[2]  
Aragon T.J., 2020, epitools: Epidemiology Tools
[3]   Impaired Innate COPD Alveolar Macrophage Responses and Toll-Like Receptor-9 Polymorphisms [J].
Berenson, Charles S. ;
Kruzel, Ragina L. ;
Wrona, Catherine T. ;
Mammen, Manoj J. ;
Sethi, Sanjay .
PLOS ONE, 2015, 10 (09)
[4]   Toll-Like Receptor (TLR2 and TLR4) Polymorphisms and Chronic Obstructive Pulmonary Disease [J].
Budulac, Simona E. ;
Boezen, H. Marike ;
Hiemstra, Pieter S. ;
Lapperre, Therese S. ;
Vonk, Judith M. ;
Timens, Wim ;
Postma, Dirkje S. .
PLOS ONE, 2012, 7 (08)
[5]   Cigarette Smoke-Induced Respiratory Response: Insights into Cellular Processes and Biomarkers [J].
Cha, Sang-Ryul ;
Jang, Jimin ;
Park, Sung-Min ;
Ryu, Se Min ;
Cho, Seong-Joon ;
Yang, Se-Ran .
ANTIOXIDANTS, 2023, 12 (06)
[6]   Toll-like receptors and chronic lung disease [J].
Chaudhuri, N ;
Dower, SK ;
Whyte, MKB ;
Sabroe, I .
CLINICAL SCIENCE, 2005, 109 (02) :125-133
[7]   Toll-like receptors: Activation, signalling and transcriptional modulation [J].
De Nardo, Dominic .
CYTOKINE, 2015, 74 (02) :181-189
[8]  
Global Initiative for Chronic Obstructive Lung Disease - GOLD, GLOBAL INITIATIVE CH
[9]   SNPassoc:: an R package to perform whole genome association studies [J].
Gonzalez, Juan R. ;
Armengol, Lluis ;
Sole, Xavier ;
Guino, Elisabet ;
Mercader, Josep M. ;
Estivill, Xavier ;
Moreno, Victor .
BIOINFORMATICS, 2007, 23 (05) :644-645
[10]   Evaluation of the toll-like receptor 6 Ser249Pro polymorphism in patients with asthma, atopic dermatitis and chronic obstructive pulmonary disease [J].
Hoffjan, S ;
Stemmler, S ;
Parwez, Q ;
Petrasch-Parwez, E ;
Arinir, U ;
Rohde, G ;
Reinitz-Rademacher, K ;
Schultze-Werninghaus, G ;
Bufe, A ;
Epplen, JT .
BMC MEDICAL GENETICS, 2005, 6